Showing results (51-60 of 105) with videos related to

Sort By:
Pageof 11
European Journal of Haematology|November 15, 2024
Development and Clinical Validation of Liquid Chromatography-Tandem Mass Spectrometry for Measuring Ruxolitinib in Steroid-Refractory Graft-Versus-Host Disease: A First Step Towards Optimized TreatmentSara Redondo, María Costa, Maria-Estela Moreno-Martinez, et al.
British Journal of Haematology|October 14, 2009
Lymphoma cell VEGFR2 expression detected by immunohistochemistry predicts poor overall survival in diffuse large B cell lymphoma treated with immunochemotherapy (R-CHOP)Dita Gratzinger, Ranjana Advani, Shuchun Zhao, et al.
Histopathology|January 29, 2014
Focal adhesion protein expression in human diffuse large B-cell lymphomaRosa Bosch, Rebeca Dieguez-Gonzalez, María José Moreno, et al.
Haematologica|June 17, 2021
Efficacy and safety assessment of prolonged maintenance with subcutaneous rituximab in patients with relapsed or refractory indolent non-Hodgkin lymphoma: results of the phase III MabCute studySimon Rule, Wolney Gois Barreto, Javier Briones, et al.
Mediators of Inflammation|March 14, 2014
Impact of cyclosporine levels on the development of acute graft versus host disease after reduced intensity conditioning allogeneic stem cell transplantationIrene García Cadenas, David Valcarcel, Rodrigo Martino, et al.
Haematologica|November 21, 2007
Prospective phase II trial of extended treatment with rituximab in patients with B-cell post-transplant lymphoproliferative diseaseEva González-Barca, Eva Domingo-Domenech, Francisco Javier Capote, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 27, 2012
Updated experience with inolimomab as treatment for corticosteroid-refractory acute graft-versus-host diseaseIrene García-Cadenas, David Valcárcel, Rodrigo Martino, et al.
Transplantation and Cellular Therapy|November 10, 2021
Efficacy and Safety of Ruxolitinib in Steroid-Refractory/Dependent Chronic Graft-versus-Host Disease: Real-World Data and ChallengesSara Redondo, Albert Esquirol, Silvana Novelli, et al.
Blood|May 1, 2008
Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with R-CHOPRaquel Malumbres, Jun Chen, Rob Tibshirani, et al.
Mycopathologia|June 22, 2020
Low Rate of Invasive Fungal Infections During Induction and Consolidation Chemotherapy for Adults with De Novo Acute Myeloid Leukemia Without Anti-mold Prophylaxis: Single-Center 2002-2018 Empirical/Pre-emptive ApproachRodrigo Martino, Ana Garrido, Marta Santaliestra, et al.
Pageof 11